Lisdexamfetamine dimesylate
- Level
- Commodity
- Parent
- 51144100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51144127This classification denotes a cns stimulant and anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SJT761GEGS. European Medicines Agency schedules Lisdexamfetamine dimesylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32146. Lisdexamfetamine dimesylate generally arises in the molecular formula C15H25N3O.2CH4O3S. The term 'lisdexamfetamine dimesylate' is a U.S. FDA Orange Book designation. Most nations, for tariff and trade purposes, schedule lisdexamfetamine dimesylate under HS 29242990. As of Q4 2014, LISDEXAMFETAMINE DIMESYLATE remains US FDA's Preferred Term for this commodity. Lisdexamfetamine dimesylate bears US NLM identifiers UMLS ID C1739826 and NCI Concept Code C76628. SMILES: C[C@@H](CC1CCCCC1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O.
Same parent
Under 51144100 · 31Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.